5-amino-1mq dosage for fat loss Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high diet-induced obesity in mice Peptides are promoted as treatments

MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal studies report wide therapeutic window Known interactions Methyl-donor depletion theoretical with chronic dosing (NNMT methylates nicotinamide using SAM) Contraindications Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Not FDA-approved

Do you gain weight back after stopping lipotropic injections

As of June 2026, 5-Amino-1MQ has no FDA-approved use

Notable recent developments include the first preclinical study demonstrating NNMT inhibition improves cardiac function and reduces fibrosis in a heart failure model (Li et al., 2025), a comprehensive review of NNMT as a therapeutic target for neurodegenerative disorders (Liu et al., 2025), and emerging evidence that NNMT inhibition counteracts tubular senescence and fibrosis in chronic kidney disease